Literature DB >> 17273861

Predictive value of clinical and laboratory variables for vesicoureteral reflux in children.

Alper Soylu1, Belde Kasap, Korcan Demir, Mehmet Türkmen, Salih Kavukçu.   

Abstract

We aimed to determine the predictability of clinical and laboratory variables for vesicoureteral reflux (VUR) in children with urinary tract infection (UTI). Data of children with febrile UTI who underwent voiding cystoureterography between 2002 and 2005 were evaluated retrospectively for clinical (age, gender, fever > or = 38.5 degrees C, recurrent UTI), laboratory [leukocytosis, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), pyuria, serum creatinine (S(Cr))] and imaging (renal ultrasonography) variables. Children with VUR (group 1) vs. no VUR (group 2) and children with high-grade (III-V) VUR (group 3) vs. no or low-grade (I-II) VUR (group 4) were compared. Among 88 patients (24 male), 38 had VUR and 21 high-grade VUR. Fever > or = 38.5 degrees C was associated with VUR [odds ratio (OR): 7.5]. CRP level of 50 mg/l was the best cut-off level for predicting high-grade VUR (OR 15.5; discriminative ability 0.89 +/- 0.05). Performing voiding cystourethrography based on this CRP level would result in failure to notice 9% of patients with high-grade VUR, whereas 69% of children with no/low-grade VUR would be spared from this invasive test. In conclusion, fever > or = 38 degrees C and CRP > 50 mg/l seem to be potentially useful clinical predictors of VUR and high-grade VUR, respectively, in pediatric patients with UTI. Further validation of these findings could limit unnecessary voiding cystourethrography.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273861     DOI: 10.1007/s00467-006-0418-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Prediction of vesicoureteral reflux after a first febrile urinary tract infection in children: validation of a clinical decision rule.

Authors:  S Leroy; E Marc; C Adamsbaum; D Gendrel; G Bréart; M Chalumeau
Journal:  Arch Dis Child       Date:  2005-05-12       Impact factor: 3.791

2.  Vesicoureteral reflux increases the risk of renal scars: a study of unilateral reflux.

Authors:  Joo Hoon Lee; Chang Hee Son; Moo Song Lee; Young Seo Park
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

Review 3.  Vesicoureteral reflux in infants.

Authors:  U Sillén
Journal:  Pediatr Nephrol       Date:  1999-05       Impact factor: 3.714

4.  Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection.

Authors:  Sandrine Leroy; Catherine Adamsbaum; Elisabeth Marc; Florence Moulin; Josette Raymond; Dominique Gendrel; Gérard Bréart; Martin Chalumeau
Journal:  Pediatrics       Date:  2005-05-02       Impact factor: 7.124

Review 5.  May we go on with antibacterial prophylaxis for urinary tract infections?

Authors:  R Beetz
Journal:  Pediatr Nephrol       Date:  2005-10-21       Impact factor: 3.714

Review 6.  Acute urinary tract infection--evaluation and treatment.

Authors:  Stanley Hellerstein
Journal:  Curr Opin Pediatr       Date:  2006-04       Impact factor: 2.856

Review 7.  Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials.

Authors:  D Wheeler; D Vimalachandra; E M Hodson; L P Roy; G Smith; J C Craig
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

Review 8.  Urinary tract infections in infants and children: a comprehensive overview.

Authors:  Ellen Wald
Journal:  Curr Opin Pediatr       Date:  2004-02       Impact factor: 2.856

9.  Imaging studies after a first febrile urinary tract infection in young children.

Authors:  Alejandro Hoberman; Martin Charron; Robert W Hickey; Marc Baskin; Diana H Kearney; Ellen R Wald
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

Review 10.  Urinary tract infections. Old and new concepts.

Authors:  S Hellerstein
Journal:  Pediatr Clin North Am       Date:  1995-12       Impact factor: 3.278

View more
  7 in total

Review 1.  Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.

Authors:  Nader Shaikh; Jessica L Borrell; Josh Evron; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

2.  Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.

Authors:  Kai J Shaikh; Victor A Osio; Mariska Mg Leeflang; Nader Shaikh
Journal:  Cochrane Database Syst Rev       Date:  2020-09-10

3.  Assessment and modeling of routinely used biochemical laboratory data of healthy individuals and end-stage renal failure (ESRF) patients by three different chemometric methods.

Authors:  Agelos Papaioannou; George Rigas; Panagiotis Plageras; George A Karikas; George Karamanis
Journal:  J Clin Lab Anal       Date:  2013-05       Impact factor: 2.352

4.  Stone expulsion rate of small distal ureteric calculi could be predicted with plasma C-reactive protein.

Authors:  Hussein A Aldaqadossi
Journal:  Urolithiasis       Date:  2013-03-07       Impact factor: 3.436

Review 5.  Dimercaptosuccinic acid scan or ultrasound in screening for vesicoureteral reflux among children with urinary tract infections.

Authors:  Nader Shaikh; Russell B Spingarn; Stephanie W Hum
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05

6.  Are clinical, laboratory, and imaging markers suitable predictors of vesicoureteral reflux in children with their first febrile urinary tract infection?

Authors:  Abolfazl Mahyar; Parviz Ayazi; Shiva Mavadati; Sonia Oveisi; Morteza Habibi; Shiva Esmaeily
Journal:  Korean J Urol       Date:  2014-08-08

7.  Serum interleukin -8 is not a reliable marker for prediction of vesicoureteral reflux in children with febrile urinary tract infection.

Authors:  Abolfazl Mahyar; Parviz Ayazi; Mohammad Hadi Yarigarravesh; Mohammad Hossein Khoeiniha; Sonia Oveisi; Ahmad Ali Sahmani; Shiva Esmaeily
Journal:  Int Braz J Urol       Date:  2015 Nov-Dec       Impact factor: 1.541

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.